This year’s meeting brings together a variety of healthcare professionals to solve the industry’s most pressing issues and define managed care pharmacy’s future. Registration is required until April 26, 2021. For more information, and to view all presentations, please visit https://2021.amcpannual.org/.
C40 | Comparison of Healthcare Resource Utilization and Total Direct Costs of Care Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following First-Line Treatment with Ibrutinib or Chemoimmunotherapy
Volodarsky R1, Singhal M2, Smith JL2, Iyengar R1, Challagulla S1
1Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA, 2HealthCore, Inc., Wilmington, DE, USA
I9 | Healthcare Resource Utilization and Costs of Obstructive Hypertrophic Cardiomyopathy in a US Managed Care Population
Butzner M1, Sarocco P1, Maron M2, Rowin E2, Teng CC3, Stanek E3, Tan H3, Robertson L1
1Cytokinetics, Inc., San Francisco, CA, 2Hypertrophic Cardiomyopathy Center and Research Institute, Boston, MA, 3Healthcore, Inc., Wilmington, DE
Z7 | The Influence of Health Plan Deductibles on Access to and Use of Treatments for Breast, Colorectal and Lung Cancer Patients
Nichols D1, Sussell J1, Teng CC2
1Genentech, Inc., South San Francisco, CA, 2HealthCore, Inc., Wilmington, DE
*HealthCore authors are indicated in bold.